Isolagen to Present at the Cowen and Company 27th Annual Health Care Conference
March 09 2007 - 8:00AM
PR Newswire (US)
EXTON, Pa., March 9 /PRNewswire-FirstCall/ -- Isolagen, Inc.
(AMEX:ILE) today announced that it has been invited to present at
the Cowen and Company 27th Annual Health Care Conference on
Thursday, March 15, 2007 at 10:15 a.m. EST. The conference will be
held at the Boston Marriott Copley Place Hotel. The presentation
will be webcast live and can be accessed by visiting the investor
relations section of the Company's website at
http://www.isolagen.com/. The presentation will be given by
Nicholas L. Teti, Jr., Isolagen's Chairman and Chief Executive
Officer. A replay will be available on the Company's website after
the presentation and will be archived for 30 days. About Isolagen,
Inc. Isolagen specializes in the development of autologous cellular
therapies for soft and hard tissue regeneration. The company's
product candidates are based on its proprietary Isolagen Process.
Autologous cellular therapy is the process whereby a patient's own
cells are extracted, allowed to multiply and then injected into the
patient. Isolagen's product candidates are designed to be minimally
invasive and non-surgical. For additional information, please
visit: http://www.isolagen.com/. All statements in this news
release that are not based on historical fact are "forward-looking
statements" within the meaning of the Private Securities Litigation
Reform Act of 1995 and the provisions of Section 27A of the
Securities Act of 1933, as amended, and Section 21E of the
Securities Exchange Act of 1934, as amended. While management has
based any forward-looking statements contained herein on its
current expectations, the information on which such expectations
were based may change. These forward-looking statements rely on a
number of assumptions concerning future events and are subject to a
number of risks, uncertainties, and other factors, many of which
are outside of our control, that could cause actual results to
materially differ from such statements. Such risks, uncertainties,
and other factors include, but are not necessarily limited to,
those set forth under Item 1A "Risk Factors" in the Company's
Annual Report on Form 10-K for the year ended December 31, 2005, as
updated in "Item 1A. Risk Factors" in the Company's Quarterly
Reports on Form 10-Q. We operate in a highly competitive and
rapidly changing environment, thus new or unforeseen risks may
arise. Accordingly, investors should not place any reliance on
forward-looking statements as a prediction of actual results. We
disclaim any intention to, and undertake no obligation to, update
or revise any forward-looking statements. Readers are also urged to
carefully review and consider the other various disclosures in the
Company's Annual Report on Form 10-K for the year ended December
31, 2005, as well as other public filings with the SEC since such
date. DATASOURCE: Isolagen, Inc. CONTACT: investors, Charles Huiner
of Isolagen, +1-484-713-6200, or Web site: http://www.isolagen.com/
Copyright
Isolagen (AMEX:ILE)
Historical Stock Chart
From Jun 2024 to Jul 2024
Isolagen (AMEX:ILE)
Historical Stock Chart
From Jul 2023 to Jul 2024